PURPURA, THROMBOCYTOPENIC

Clinical trials for PURPURA, THROMBOCYTOPENIC explained in plain language.

Never miss a new study

Get alerted when new PURPURA, THROMBOCYTOPENIC trials appear

Sign up with your email to follow new studies for PURPURA, THROMBOCYTOPENIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Trial for new bleeding disorder pill withdrawn before starting

Disease control Terminated

This was an early-stage study to test the safety and find the right dose of a new oral drug called HMPL-523 for adults with immune thrombocytopenia (ITP), a condition where the immune system attacks platelets, causing a risk of bleeding. The study was designed to enroll adults wh…

Matched conditions: PURPURA, THROMBOCYTOPENIC

Phase: PHASE1 • Sponsor: Hutchmed • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

PURPURA, THROMBOCYTOPENIC

Get alerted when new PURPURA, THROMBOCYTOPENIC trials appear

Trial for new bleeding disorder pill withdrawn before starting